Evidence map›Paper›PMID 20658321›Full record

ReviewMycopathologia2011

Microsporum praecox: molecular identification of a new case and review of the literature.

Alexandre Alanio, Stéphane Romand, Dominique Penso-Assathiany, Françoise Foulet, Françoise Botterel

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Mycopathologia, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. [Tinea corporis due to the rare geophilic dermatophyte Microsporum praecox].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2017
    Article
  5. Review
  6. [Sports-associated dermatophytoses : An overview].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alexandre AlanioLaboratoire de Parasitologie-Mycologie, Hôpital Henri Mondor, (AP-HP) Créteil, Université Paris Est, 51 avenue du Maréchal De Lattre de Tassigny, 94010, Créteil, France.
Stéphane Romand
Dominique Penso-Assathiany
Françoise Foulet
Françoise Botterel
Assistance Publique – Hôpitaux de Paris · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a rare case of dermatophytosis due to Microsporum praecox in a 28-year-old female horse rider. The skin lesion was located on the right external malleolus. Microscopic examination of skin scrapings revealed a dermatophyte which was also isolated in culture. The identification of M. praecox was confirmed by molecular biology (sequence analysis of PCR products amplified from internal transcribed spacer regions with universal primers). Combined antifungal therapy with oral terbinafine and topical cyclopiroxolamide resulted in complete remission of the fungal lesion within 1 month. Since 1944, only 29 cases of human M. praecox infection have been reported in the literature. The clinical features and treatment of these cases are reviewed. The prevalence of M. praecox infection is probably underestimated, and systematic molecular identification could improve our understanding of the epidemiology of this fungal dermatosis.

Indexed as

AdultAntifungal AgentsCiclopiroxDermatomycosesDNA, FungalDNA, Ribosomal SpacerFemaleHumansMicrosporumNaphthalenesPhylogenyPyridonesSequence Analysis, DNASkinTerbinafineTreatment OutcomeAntifungal AgentsCiclopiroxDNA, FungalDNA, Ribosomal SpacerNaphthalenesPyridonesTerbinafine

Identifiers

PMID20658321
OpenAlexW2025825311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.